ASTRO updates guideline on radiation therapy for pancreatic cancer

medicalxpress - An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based recommendations on the use of radiation therapy to treat adult patients with pancreatic cancer.

AI Summary: ASTRO released updated 2026 guidance for radiation therapy in pancreatic cancer, refining target volumes, dose constraints, and technique recommendations. The update aims to standardize practice, improve safety for nearby organs at risk, and incorporate emerging evidence on hypofractionation and concurrent systemic therapies to better balance local control with toxicity.

#healthcare #oncology #pancreaticcancer #cancerresearch #clinicaltrials

10 days / oncodaily

12 days / oncodaily

15 days / oncodaily

16 days / medicalxpress


Back to Top / Sat, August 15, 2026, 11:22 am / permalink 28829 / 4 stories in 14 days /




Related Stories


Small study reports 100% one‑year survival after lung transplant / 7 wks

High‑dose targeted radiation shows promise for huge bile duct tumors / 4 months

Two high‑dose radiotherapy sessions safely treat localized prostate cancer / 3 months

ESMO issues new metastatic colorectal cancer clinical guideline / 4 months

Daraxonrasib’s ASCO moment sparks rapid clinical uptake for pancreatic cancer / 2 months

Daraxonrasib improves survival versus chemotherapy in metastatic pancreatic cancer / 2 months

ASCO names 2027 FASCO fellows, honoring oncology leaders / 4 wks

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Healthcare Finance, Genetics, Pancreatic Cancer, Nutrition and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.